| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $21.6B | — | — | — | — |
| Op. Income | $3.7B | — | — | — | — |
| Gross Margin | 33.8% | — | — | — | — |
| Net Margin | 11.0% | — | — | — | — |
| EPS (Diluted) | $1.61 | — | — | — | — |
| Free Cash Flow | $4.1B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $21.6B |
| Cost of Revenue | $14.3B |
| GROSS PROFIT | $7.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $986M |
| Other Expenses | $2.6B |
| Operating Expenses | $3.6B |
| Cost & Expenses | $17.9B |
| OPERATING INCOME | $3.7B |
| Interest Income | $219M |
| Interest Expense | $900M |
| Other Income/Expenses | -$594M |
| INCOME BEFORE TAX | $3.1B |
| Income Tax Expense | $1.0B |
| Net Income from Continuing Ops | $2.1B |
| Net Income from Discontinued Ops | $262M |
| Other Adjustments | $0 |
| NET INCOME | $2.4B |
| Net Income Deductions | $70M |
| BOTTOM LINE NET INCOME | $1.6B |
| D&A | $7.6B |
| EBIT | $3.7B |
| EBITDA | $11.4B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $21.6B |
| Cost of Revenue | $14.3B |
| GROSS PROFIT | $7.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $986M |
| Other Expenses | $2.6B |
| Operating Expenses | $3.6B |
| Cost & Expenses | $17.9B |
| OPERATING INCOME | $3.7B |
| Interest Income | $219M |
| Interest Expense | $900M |
| Other Income/Expenses | -$594M |
| INCOME BEFORE TAX | $3.1B |
| Income Tax Expense | $1.0B |
| Net Income from Continuing Ops | $2.1B |
| Net Income from Discontinued Ops | $262M |
| Other Adjustments | $0 |
| NET INCOME | $2.4B |
| Net Income Deductions | $70M |
| BOTTOM LINE NET INCOME | $1.6B |
| D&A | $7.6B |
| EBIT | $3.7B |
| EBITDA | $11.4B |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $2.4B |
| Depreciation & Amortization | $7.5B |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $127M |
| Other Non-Cash Items | $1.6B |
| Change in Working Capital | -$1.1B |
| OPERATING CASH FLOW | $10.5B |
| Capital Expenditure | -$6.4B |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$280M |
| Sales/Maturities of Investments | $2.3B |
| Other Investing Activities | -$1.4B |
| NET CASH FROM INVESTING | -$5.8B |
| Net Debt Issuance | -$3.8B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$1.6B |
| Other Financing Activities | -$462M |
| NET CASH FROM FINANCING | -$4.8B |
| FREE CASH FLOW | $4.1B |
| Net Change in Cash | -$111M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.0B |
| Short-Term Investments | $0 |
| Net Receivables | $3.3B |
| Inventory | $1.8B |
| Other Current Assets | $1.7B |
| TOTAL CURRENT ASSETS | $8.8B |
| PP&E (Net) | $64.6B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $3.0B |
| Tax Assets | $2.6B |
| Other Non-Current Assets | $7.8B |
| TOTAL NON-CURRENT ASSETS | $78.0B |
| TOTAL ASSETS | $86.8B |
| Account Payables | $3.3B |
| Short-Term Debt | $2.1B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $2.9B |
| TOTAL CURRENT LIABILITIES | $9.4B |
| Long-Term Debt | $20.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $8.2B |
| Other Non-Current Liabilities | $10.7B |
| TOTAL NON-CURRENT LIABILITIES | $40.8B |
| TOTAL LIABILITIES | $50.2B |
| Common Stock | $243M |
| Additional Paid-In Capital | $21.0B |
| Retained Earnings | $21.9B |
| Treasury Stock | -$15.6B |
| Accum. Other Comp. Income | $202M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $36.0B |
| Minority Interest | $564M |
| TOTAL EQUITY | $36.6B |
| TOTAL LIABILITIES & EQUITY | $86.8B |
| Total Debt | $24.0B |
| Net Debt | $22.0B |